Man's best friend may soon visit the ICU: feasibility study launches
NCT ID NCT07159568
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study looks at whether it's practical and safe for ICU patients to have short visits from their own pet dogs. Researchers will test this with 21 adult patients in three ICUs in France. The dog can stay for up to 15 minutes, and staff will check for any problems. The goal is to see if such visits can become a regular option to help patients feel better.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Pet dog visit
What this could lead to
If successful, this could pave the way for pet visits in ICUs, potentially improving patient well-being and comfort during a stressful hospital stay.
What could go wrong
This is a very small feasibility study with only 21 participants, so results may not apply widely. There are risks like infection or accidental dislodgement of medical equipment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTENSIVE CARE UNIT (ICU) PATIENTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU Clermont-Ferrand
Clermont-Ferrand, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact